CANDEL THERAPEUTICS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.83 USD | +3.27% |
|
-16.45% | +501.36% |
Chart calendar Candel Therapeutics, Inc.
9ba704f0fa0de53d93.EX8ypLqzrAugZxjb2Kp5wYIhF7ypRcKWGjtzzTrJEkU.JB4B4Pvgn0-VUVKisdAspPFkcNPTCK_UXXw6h3aEZz10B3nz1_zff_INfw~25df243d729c871c789042a546d16c60
Upcoming events on Candel Therapeutics, Inc.
Past events on Candel Therapeutics, Inc.
| 2024-05-14 08:00 am | Q1 2024 Earnings Release |
| 2024-04-09 12:00 pm | American Association for Cancer Research Meeting - Abstract No - LB263 |
| 2024-03-28 08:05 am | Q4 2023 Earnings Release |
| 2024-03-27 | Glioblastoma Drug Development Summit |
| 2023-11-09 08:00 am | Q3 2023 Earnings Release |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number :1096 |
| 2023-11-04 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number :1348 |
| 2023-11-03 12:00 pm | Society for Immunotherapy of Cancer Meeting - Abstract Number :653 |
| 2023-09-11 03:00 pm | H.C. Wainwright Global Investment Conference |
| 2023-08-10 11:30 am | Canaccord Genuity Growth Conference |
| 2023-08-10 08:00 am | Q2 2023 Earnings Release |
| 2023-06-28 10:00 am | Annual General Meeting |
| 2023-06-07 04:00 pm | Jefferies Global Healthcare Conference |
| 2023-06-04 09:00 am | American Society of Clinical Oncology Conference - Charu Aggarwal |
| 2023-05-19 11:00 am | American Society of Gene Cell Therapy Meeting - Francesca Barone |
| 2023-05-11 08:00 am | Q1 2023 Earnings Release |
| 2023-03-30 08:00 am | Q4 2022 Earnings Release |
| 2023-02-08 03:20 pm | Guggenheim Oncology Conference |
| 2023-01-19 11:30 am | B. Riley Securities Oncology Conference |
| 2022-12-06 11:00 am | R&D Day |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,13 0,03 278.79% | 0,13 0,11 15.39% | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -25,5 -24,0 -6.44% | -33,9 -37,1 8.58% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -25,7 -26,4 2.59% | -34,7 -36,4 4.57% | -38,4 -37,3 -2.92% | -46,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -36,1 -47,5 23.95% | -18,8 -21,8 13.59% | -37,9 -31,6 -20.06% | -41,6 |
|
Net income Million USD | Released Forecast Spread | -36,1 -40,7 11.24% | -18,8 -21,8 13.59% | -37,9 -31,6 -20.06% | -41,6 |
|
EPS USD | Released Forecast Spread | -1,91 -2,14 10.9% | -0,65 -0,70 7.75% | -1,31 -1,09 -20.18% | -0,91 |
| Announcement Date | 29/03/22 | 30/03/23 | 28/03/24 | - |
Quarterly results
| Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,03 0,02 100% | 0,03 0,00 - | 0,03 0,01 200.1% | 0,03 0,01 121.43% | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | |
|
EBITDA Million USD | Released Forecast Spread | -8,82 -7,64 -15.52% | -8,57 -5,76 -48.61% | -8,68 -8,19 -5.89% | -7,88 | ||||
|
EBIT Million USD | Released Forecast Spread | -8,99 -10,9 17.84% | -8,75 -13,8 36.53% | -8,88 -11,7 24.23% | -8,10 -11,7 30.54% | -9,63 -10,0 3.67% | -9,58 -11,1 13.31% | -8,86 -9,90 10.49% | -10,3 -9,20 -12.15% |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -5,08 -4,80 -5.9% | -9,61 -6,60 -45.67% | -8,44 -5,40 -56.2% | -11,1 -4,70 -136.06% | ||||
|
Net income Million USD | Released Forecast Spread | -0,87 -14,2 93.85% | -4,15 -16,0 74.07% | -8,69 -16,0 45.7% | -5,08 -4,80 -5.9% | -9,61 -6,60 -45.67% | -8,44 -5,40 -56.2% | -11,1 -4,70 -136.06% | |
|
EPS USD | Released Forecast Spread | -0,03 -0,34 91.1% | -0,14 -0,45 69.12% | -0,30 -0,36 16.48% | -0,17 -0,31 44.33% | -0,30 -0,35 14.29% | -0,33 -0,30 -10% | -0,29 -0,19 -52.63% | -0,38 -0,16 -137.5% |
| Announcement Date | 12/05/22 | 05/08/22 | 10/11/22 | 30/03/23 | 11/05/23 | 10/08/23 | 09/11/23 | 28/03/24 |
| 2024-06-30 | IMMUNOVANT, INC.: Q4 2024 Earnings Release (Projected) |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
Past sector events for Candel Therapeutics, Inc.
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | NUVATION BIO INC.: Q1 2024 Earnings Release |
| 2024-05-14 07:30 am | ABSCI CORPORATION: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CADL Stock
- Calendar Candel Therapeutics, Inc.
